Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

One Year Real-World Use of the Control-IQ Advanced Hybrid Closed-Loop Technology
Marc D. Breton, Boris Kovatchev
Diabetes Technology & Therapeutics (2021) Vol. 23, Iss. 9, pp. 601-608
Open Access | Times Cited: 186

Showing 1-25 of 186 citing articles:

9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes—2024
Nuha A. ElSayed, Grazia Aleppo, Raveendhara R. Bannuru, et al.
Diabetes Care (2023) Vol. 47, Iss. Supplement_1, pp. S158-S178
Open Access | Times Cited: 297
Consensus Recommendations for the Use of Automated Insulin Delivery Technologies in Clinical Practice
Moshe Phillip, Revital Nimri, Richard M. Bergenstal, et al.
Endocrine Reviews (2022) Vol. 44, Iss. 2, pp. 254-280
Open Access | Times Cited: 230
Real-World Performance of the MiniMed™ 780G System: First Report of Outcomes from 4120 Users
Julien Da Silva, Giuseppe Lepore, Tadej Battelino, et al.
Diabetes Technology & Therapeutics (2021) Vol. 24, Iss. 2, pp. 113-119
Open Access | Times Cited: 171
14. Children and Adolescents: Standards of Care in Diabetes—2023
Nuha A. ElSayed, Grazia Aleppo, Vanita R. Aroda, et al.
Diabetes Care (2022) Vol. 46, Iss. Supplement_1, pp. S230-S253
Open Access | Times Cited: 142
Comparison of MiniMed 780G system performance in users aged younger and older than 15 years: Evidence from 12 870 real‐world users
Arcelia Arrieta, Tadej Battelino, Andrea Scaramuzza, et al.
Diabetes Obesity and Metabolism (2022) Vol. 24, Iss. 7, pp. 1370-1379
Open Access | Times Cited: 114
ISPAD Clinical Practice Consensus Guidelines 2022: Diabetes technologies: Insulin delivery
Jennifer L. Sherr, Melissa J. Schoelwer, Tiago Jeronimo Dos Santos, et al.
Pediatric Diabetes (2022) Vol. 23, Iss. 8, pp. 1406-1431
Open Access | Times Cited: 107
Type 1 diabetes
Teresa Quattrin, Lucy D. Mastrandrea, Lucy S. K. Walker
The Lancet (2023) Vol. 401, Iss. 10394, pp. 2149-2162
Closed Access | Times Cited: 102
14. Children and Adolescents: Standards of Care in Diabetes—2024
Nuha A. ElSayed, Grazia Aleppo, Raveendhara R. Bannuru, et al.
Diabetes Care (2023) Vol. 47, Iss. Supplement_1, pp. S258-S281
Open Access | Times Cited: 59
Simplified Meal Announcement Versus Precise Carbohydrate Counting in Adolescents With Type 1 Diabetes Using the MiniMed 780G Advanced Hybrid Closed Loop System: A Randomized Controlled Trial Comparing Glucose Control
Goran Petrovski, Judith Campbell, Maheen Pasha, et al.
Diabetes Care (2023) Vol. 46, Iss. 3, pp. 544-550
Open Access | Times Cited: 57
A Meta-Analysis of Randomized Trial Outcomes for the t:slim X2 Insulin Pump with Control-IQ Technology in Youth and Adults from Age 2 to 72
Roy W. Beck, Lauren G. Kanapka, Marc D. Breton, et al.
Diabetes Technology & Therapeutics (2023) Vol. 25, Iss. 5, pp. 329-342
Open Access | Times Cited: 55
A Systematic Review of Commercial Hybrid Closed-Loop Automated Insulin Delivery Systems
Sofia Peacock, Isolda Frizelle, Sufyan Hussain
Diabetes Therapy (2023) Vol. 14, Iss. 5, pp. 839-855
Open Access | Times Cited: 46
9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes—2025
Nuha A. ElSayed, Rozalina G. McCoy, Grazia Aleppo, et al.
Diabetes Care (2024) Vol. 48, Iss. Supplement_1, pp. S181-S206
Closed Access | Times Cited: 45
Real-World Evidence of Omnipod® 5 Automated Insulin Delivery System Use in 69,902 People with Type 1 Diabetes
Gregory P. Forlenza, Daniel J. DeSalvo, Grazia Aleppo, et al.
Diabetes Technology & Therapeutics (2024) Vol. 26, Iss. 8, pp. 514-525
Open Access | Times Cited: 18
Real-World Evidence of Automated Insulin Delivery System Use
Elizabeth G. Considine, Jennifer L. Sherr
Diabetes Technology & Therapeutics (2024) Vol. 26, Iss. S3, pp. 53-65
Closed Access | Times Cited: 15
Randomized Trial of Assisted Hybrid Closed-Loop Therapy Versus Sensor-Augmented Pump Therapy in Pregnancy
Sarit Polsky, Elizabeth Buschur, Kathleen Dungan, et al.
Diabetes Technology & Therapeutics (2024) Vol. 26, Iss. 8, pp. 547-555
Closed Access | Times Cited: 15
Current Advances of Artificial Pancreas Systems: A Comprehensive Review of the Clinical Evidence
Sun Joon Moon, Inha Jung, Cheol‐Young Park
Diabetes & Metabolism Journal (2021) Vol. 45, Iss. 6, pp. 813-839
Open Access | Times Cited: 65
Cambridge hybrid closed-loop algorithm in children and adolescents with type 1 diabetes: a multicentre 6-month randomised controlled trial
Julia Ware, Charlotte K. Boughton, Janet M. Allen, et al.
The Lancet Digital Health (2022) Vol. 4, Iss. 4, pp. e245-e255
Open Access | Times Cited: 63
Current Status and Emerging Options for Automated Insulin Delivery Systems
Gregory P. Forlenza, Rayhan A. Lal
Diabetes Technology & Therapeutics (2022) Vol. 24, Iss. 5, pp. 362-371
Open Access | Times Cited: 47
Glycemic outcomes of Advanced Hybrid Closed Loop system in children and adolescents with Type 1 Diabetes, previously treated with Multiple Daily Injections (MiniMed 780G system in T1D individuals, previously treated with MDI)
Goran Petrovski, Fawziya Al Khalaf, Judith Campbell, et al.
BMC Endocrine Disorders (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 44
Advances in Continuous Glucose Monitoring and Integrated Devices for Management of Diabetes with Insulin-Based Therapy: Improvement in Glycemic Control
Jee Hee Yoo, Jae Hyeon Kim
Diabetes & Metabolism Journal (2023) Vol. 47, Iss. 1, pp. 27-41
Open Access | Times Cited: 40
Real-World Evidence Supporting Tandem Control-IQ Hybrid Closed-Loop Success in the Medicare and Medicaid Type 1 and Type 2 Diabetes Populations
Gregory P. Forlenza, Anders L. Carlson, Rodolfo J. Galindo, et al.
Diabetes Technology & Therapeutics (2022) Vol. 24, Iss. 11, pp. 814-823
Open Access | Times Cited: 39
Hybrid Closed-Loop Therapy in Adults With Type 1 Diabetes and Above-Target HbA1c: A Real-world Observational Study
Thomas Crabtree, Tomás P. Griffin, Yew W. Yap, et al.
Diabetes Care (2023) Vol. 46, Iss. 10, pp. 1831-1838
Open Access | Times Cited: 34
Offline reinforcement learning for safer blood glucose control in people with type 1 diabetes
Harry Emerson, Matthew Guy, Ryan McConville
Journal of Biomedical Informatics (2023) Vol. 142, pp. 104376-104376
Open Access | Times Cited: 32
A Multicenter Prospective Evaluation of the Benefits of Two Advanced Hybrid Closed-Loop Systems in Glucose Control and Patient-Reported Outcomes in a Real-world Setting
Pilar Isabel Beato-Víbora, Ana Chico, Jesús Moreno-Fernández, et al.
Diabetes Care (2023) Vol. 47, Iss. 2, pp. 216-224
Open Access | Times Cited: 26
One-year follow-up comparison of two hybrid closed-loop systems in Italian children and adults with type 1 diabetes
Marta Bassi, Luca Patti, Irene Silvestrini, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 22
Page 1 - Next Page

Scroll to top